Holen Sie sich die Stockscreener-App
3.91
0.26%
0.01
Handel nachbörslich:
3.81
-0.10
-2.56%
Whitehawk Therapeutics Inc Aktie (WHWK) Neueste Nachrichten
Whitehawk Therapeutics (WHWK) Swings To US$0.37 EPS Profit Challenging Bearish Turnaround Skepticism - simplywall.st
Whitehawk Therapeutics Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Whitehawk Therapeutics 2025 10-K Overview: Next-Generation ADC Cancer Therapies, Pipeline, and Strategic Partnerships - Minichart
WHITEHAWK THERAPEUTICS ($WHWK) Releases Q4 2025 Earnings - Quiver Quantitative
Whitehawk Therapeutics Q4 EPS $(0.34) Misses $(0.13) EstimateWhitehawk Therapeutics (NASDAQ:WHWK) - Benzinga
Whitehawk Therapeutics reports bigger-than-expected Q4 loss on higher R&D costs - TradingView
Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights - PR Newswire
Whitehawk Therapeutics (WHWK) price target increased by 11.11% to 5.10 - MSN
David James Lennon Sells 5,100 Shares of Whitehawk Therapeutics (NASDAQ:WHWK) Stock - MarketBeat
Aadi Bioscience Conference: Whitehawk Unveils 3-Program ADC Pipeline, Targets First Data in 2027 - Yahoo Finance
Why Whitehawk Therapeutics Inc. stock is a value investor pickEarnings Beat & Verified Chart Pattern Trade Signals - Naître et grandir
Insider Trends: What are the risks of holding Whitehawk Therapeutics IncWeekly Risk Summary & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Can Whitehawk Therapeutics Inc reach resistance levels soon2025 Market Trends & Low Risk Entry Point Guides - baoquankhu1.vn
Aadi Bioscience Conference: Whitehawk CEO Details 3-Program ADC Pipeline, First Data Seen in 2027 - Defense World
Aug Closing: Can Whitehawk Therapeutics Inc reach resistance levels soonJuly 2025 Short Interest & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Whitehawk Therapeutics : Corporate Presentation March 2026 - marketscreener.com
WHWK: Three differentiated ADCs in parallel, targeting broad cancers with best-in-class stability and safety - TradingView
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences - PR Newswire
Cancer drug developer Whitehawk lines up three March investor talks - Stock Titan
Whitehawk Therapeutics (WHWK) Price Target Increased by 11.11% to 5.10 - Nasdaq
Aadi Bioscience Conference: CEO Spotlights Whitehawk ADC Pipeline, Cash Runway Through 2028 - Yahoo Finance
WHWK Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cancer drug developer Whitehawk joins Oppenheimer health conference - Stock Titan
Can Whitehawk Therapeutics Inc. (3350) stock sustain double digit ROEJuly 2025 Chart Watch & Low Risk Entry Point Guides - mfd.ru
Can Whitehawk Therapeutics Inc. (3350) stock reach $200 price targetMarket Sentiment Report & Daily Entry Point Trade Alerts - mfd.ru
How Whitehawk Therapeutics Inc. stock reacts to global recession fearsTrade Entry Summary & Fast Momentum Entry Tips - mfd.ru
Will Whitehawk Therapeutics Inc. outperform tech stocksJuly 2025 Volume & High Win Rate Trade Tips - mfd.ru
Is Whitehawk Therapeutics Inc.’s growth already priced in2025 Fundamental Recap & High Accuracy Investment Entry Signals - mfd.ru
Published on: 2026-02-13 19:37:08 - baoquankhu1.vn
Will Whitehawk Therapeutics Inc. stock deliver strong dividend growthChart Signals & Long-Term Capital Growth Strategies - mfd.ru
Is Whitehawk Therapeutics Inc. stock technically oversold2025 Major Catalysts & Reliable Price Breakout Alerts - mfd.ru
Oppenheimer Begins Coverage on Whitehawk Therapeutics (NASDAQ:WHWK) - Defense World
Oppenheimer initiates Whitehawk Therapeutics (WHWK) with Outperform Feb 2026 - Meyka
Oppenheimer Initiates Coverage on Whitehawk Therapeutics (NASDAQ:WHWK) - MarketBeat
Whitehawk Therapeutics (NASDAQ:WHWK) Trading 0.7% HigherStill a Buy? - MarketBeat
Retail Trends: Can FreightCar America Inc be recession proofJuly 2025 Market Mood & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Aug Reactions: Will Whitehawk Therapeutics Inc outperform tech stocks2025 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Will Whitehawk Therapeutics Inc outperform the market in YEAR2025 Key Highlights & High Conviction Trade Alerts - baoquankhu1.vn
Investment Recap: Will Whitehawk Therapeutics Inc outperform the market in YEAR2025 Investor Takeaways & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Whitehawk Therapeutics (WHWK) price target increased by 125.00% to 4.59 - MSN
Support Test: Should I set a stop loss on Onfolio Holdings IncTake Profit & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Can Whitehawk Therapeutics Inc sustain its profitability2025 Pullback Review & Weekly Sector Rotation Insights - baoquankhu1.vn
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Shares Fly 27% But Investors Aren't Buying For Growth - simplywall.st
Whitehawk Therapeutics (WHWK) Price Target Increased by 125.00% to 4.59 - Nasdaq
Whitehawk Therapeutics (NASDAQ:WHWK) Stock Price Down 2.7%Here's What Happened - MarketBeat
Whitehawk Therapeutics (NASDAQ:WHWK) Stock Price Down 2.7% – Here’s What Happened - Defense World
Published on: 2026-01-10 19:11:09 - ulpravda.ru
Why Whitehawk Therapeutics Inc. stock is favored by top institutionsJuly 2025 Technicals & Reliable Trade Execution Plans - Улправда
Following a 26% decline over last year, recent gains may please Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) hedge funds owners - Sahm
Will Whitehawk Therapeutics Inc. stock continue upward momentumJuly 2025 Chart Watch & Verified Stock Trade Ideas - ulpravda.ru
Why Whitehawk Therapeutics Inc. stock attracts high net worth investorsWeekly Profit Summary & Free Expert Approved Momentum Trade Ideas - Улправда
How Whitehawk Therapeutics Inc. stock performs in rate cut cyclesPortfolio Growth Summary & Free Safe Entry Trade Signal Reports - ulpravda.ru
Will Whitehawk Therapeutics Inc. stock pay special dividendsEarnings Growth Summary & Weekly High Return Stock Opportunities - ulpravda.ru
Why institutional investors increase stakes in Whitehawk Therapeutics Inc. (3350) stockJuly 2025 EndofMonth & Community Trade Idea Sharing - Улправда
Whitehawk receives FDA clearance for PTK7-targeted cancer drug - Investing.com
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016 - The AI Journal
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):